English
Adult Congenital Heart Disease Interventions

Adult Congenital Heart Disease Interventions

Adult Congenital Heart Disease Interventions in Broadway

Adult congenital heart disease (ACHD) encompasses a range of heart conditions present at birth that affect the heart's structure and function. Congenital cardiac abnormalities range in severity from minor to severe and can affect the heart's ability to pump blood. Some people may stay asymptomatic or not have symptoms until they are adults, while others may get therapy as children but exhibit problems later in life. On the other hand, the prognosis for people with ACHD has greatly improved due to advances in diagnosis and therapy. Nowadays, about 90% of children with ACHD who get treatment grow up to be adults. Lifelong medical care is necessary for successful condition monitoring and management, regardless of the time of diagnosis. Regular check-ups with the doctor are required to ensure an early diagnosis.

Interventions for congenital heart disease in adults include both percutaneous and surgical interventions. Percutaneous interventions are those performed by inserting catheters through the skin and guided towards the heart. Balloon angioplasty, Transcatheter Valve Replacement or Repair, Stent Placement, Device Closure of Septal Defects are all included in the percutaneous interventions. Surgical Interventions on the other hand include Valve Repair or Replacement, Correction of Abnormal Connections, and heart transplantation procedures. Percutaneous procedures are mostly preferred due to the shortened recovery time, and reduced complications.
 

FAQ's

Atrial septal defect (ASD) is a heart defect that is present at birth (congenital). A wall known as the septum forms during foetal development, dividing the upper chamber into the left and right atriums. Improper formation of this wall may lead to a birth defect that persists. 
 

An atrial septal defect (ASD) is caused by the abnormal formation of a portion of the septum, the tissue that divides the top two heart chambers (atria). This results in an opening that does not heal itself. Cardiovascular specialists can close an ASD using cardiac catheterization, a minimally invasive procedure. During this procedure, an ASD closure device is used to seal the hole. A thin, hollow tube called a catheter is threaded up to the heart through the groyne. This method is also known as transcatheter ASD closure.
 

A ventricular septal defect (VSD) is a congenital heart defect characterised by a hole in the wall between the heart's two bottom chambers (ventricles). VSD is the most prevalent congenital heart defect, and it often coexists with other cardiac conditions. Small VSDs typically cause little to no symptoms, while larger holes may require repair to prevent further damage and complications.

The blood vessel that joins the pulmonary artery with the aorta is known as a patent ductus arteriosus (PDA). For the foetus's body to get oxygen-rich blood from the mother before birth, this route is crucial. The vessel usually shuts down soon after delivery. Blood with and without oxygen can mix if it does not close, which puts more strain on the heart. This condition should be treated when it does not close on its own.

There are several therapeutic options available for treating PDA. However, no treatment is best for all patients. The appropriate course of action for you or your child's condition should be discussed with your doctor, but there are a few common methods that you should be aware of. First, medication may be useful in managing symptoms related to the PDA or in helping to close the PDA. Additional therapeutic alternatives encompass open cardiac surgery and catheter-based interventions.
 

Pulmonary arteriovenous malformations (PAVMs) are abnormal direct connections between the branches of the pulmonary arteries and veins. These malformations are frequently seen in patients with hereditary hemorrhagic telangiectasia (HHT). If left untreated, the right-to-left shunt can cause hypoxemia, stroke, cerebral abscess, and paradoxical emboli on the left side of the circulation. Endovascular therapy, a minimally invasive outpatient procedure with little to no mortality, is used to treat PAVMs. This therapy involves obstructing the feeding artery to the PAVM with coils, plugs, or a combination of both.
 

Hormonal treatments, such as aminocaproic acid, desmopressin, octreotide, and danazol, have demonstrated some effectiveness in treating recurrent bleeding from the GI or nasopharyngeal mucosa. Furthermore, bevacizumab is effective in shortening the duration and frequency of epistaxis episodes. The gold standard for treating pulmonary arteriovenous malformations (PAVM) is either surgical excision or therapeutic embolisation. The goal of embolisation treatment is to block the feeding arteries with materials such as coils, stainless steel coils, cotton wool coils, detachable balloons, and polyvinyl alcohol. 

Percutaneous transluminal coronary angioplasty (PTCA), often known as balloon angioplasty, is a minimally invasive treatment used to unblock coronary arteries that have been clogged. To compress plaque and restore blood flow, a catheter equipped with a tiny balloon is introduced into a blood vessel, directed to the obstruction, and inflated. To keep the artery open, a stent is frequently implanted. Medication and a brief hospital stay are necessary for recovery. Bleeding, restenosis, and clots are among the risks. This less intrusive option to bypass surgery greatly relieves symptoms and lowers the risk of a heart attack.
 

A tiny mesh tube is inserted into a constricted or obstructed artery to maintain its opening during stenting, also known as stenting, which frequently happens after balloon angioplasty. This surgery lowers the risk of a heart attack, increases blood flow, and stops re-narrowing. Drug-eluting and bare-metal stents are two types. A catheter is used to guide the stent to the obstruction while the patient is under local anaesthesia. Medication and hospital supervision are necessary for recovery. Benefits include symptom alleviation and a less intrusive option to bypass surgery; risks include bleeding, clots, and damage to the arteries.